FMT for Advanced Tumor Cachexia, Phase 2
ClinicalTrials.gov Studies
Summary
NIH has registered a prospective, multicenter, single-arm Phase 2 clinical study (NCT07533227) to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) capsules in treating advanced tumor cachexia in cancer patients. The trial is listed on ClinicalTrials.gov as a reference document.
What changed
NIH registered a new Phase 2 clinical trial on ClinicalTrials.gov studying fecal microbiota transplantation (FMT) for advanced tumor cachexia in cancer patients. The single-arm study will evaluate FMT capsule efficacy and safety as an investigational treatment.
This registration provides transparency on the trial design for compliance and public access purposes. It does not impose compliance obligations but serves as an informational reference for clinical investigators, pharmaceutical researchers, and healthcare providers involved in oncology or cachexia treatment research.
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia
Phase 2 NCT07533227 Kind: PHASE2 Apr 16, 2026
Abstract
This project is a prospective, multicenter, single-arm, phase II clinical study aimed at evaluating the efficacy and safety of fecal microbiota transplantation (FMT) in treating advanced tumor cachexia.
Conditions: Cachexia; Cancer, Fecal Microbiota Transplantation (FMT)
Interventions: FMT capsule
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.